Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
AssigneeAlcobra Ltd.
InventorsRina Yamin, Dalia Megiddo, Yaron Ilan
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlcobra Ltd.
InventorsRina Yamin, Dalia Megiddo, Yaron Ilan
Estimating the term…
The present invention provides uses of a salt adduct comprising at least one positively charged moiety being a pyridoxine or a derivative thereof and at least one carboxylated 5- to 7-membered lactam ring, optionally additionally substituted, for the preparation of a medicament for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition in a subject. Additionally, the invention provides use of said salt adducts for the preparation of medicaments for the improvement of cognitive functions in a healthy subject.
Use of a salt adduct comprising at least one positively charged moiety being a pyridoxine or a derivative thereof and at least one carboxylated 5- to 7-membered lactam ring, optionally additionally substituted, for the preparation of a medicament for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition in a subject.
Use of a salt adduct comprising at least one positively charged moiety being a pyridoxine or a derivative thereof and at least one carboxylated 5- to 7-membered lactam ring, optionally additionally substituted, for the preparation of a medicament for the improvement of cognitive functions in a healthy subject.
Use according to any one of the preceding claims, wherein said carboxylated lactam ring is selected from the group consisting of:
Use according to any one of the preceding claims, wherein said salt adduct is selected from the following:
Use according to any one of the preceding claims, wherein said subject is a child, an adolescent, an adult, or an elderly person.
Use according to any one of the preceding claims, wherein said salt adduct is formulated in a sustained-, delayed or controlled-release dosage form.
Use according to any one of the preceding claims, wherein said salt adduct is formulated in a sustained-, delayed or controlled-release dosage form combined with a salt adduct formulated in an immediate or burst effect dosage form.
Use according to any one of the preceding claims, wherein said salt adduct is formulated to deliver up to 0.1-1000 mg/kg body weight/day of said salt adduct, preferably 1-400 mg/kg body weight of said salt adduct, in a single dose administration or portion thereof.
Use according to any one of the preceding claims, wherein said salt adduct is formulated together with at least one additional pharmaceutically active agent.
Dependencies are inferred from the claim text.